Fortress Biotech, Inc. Financing Cash Flow
Fortress Biotech, Inc. (FBIO) reported Financing Cash Flow of -$27.30 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-13
- Fortress Biotech, Inc. net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was $91.00K, a 97.99% decline year-over-year.
- Fortress Biotech, Inc. net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was -$27.39M, a 152.53% decline year-over-year.
- Fortress Biotech, Inc. net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was $5.71M, a 77.88% decline year-over-year.
- Fortress Biotech, Inc. net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was $15.07M, a 455.96% increase year-over-year.
- Fortress Biotech, Inc. net cash provided by (used in) financing activities for fiscal 2025 was $77.44M, a 9.63% increase from fiscal 2024.
- Fortress Biotech, Inc. net cash provided by (used in) financing activities for fiscal 2024 was $70.64M, a 115.77% increase from fiscal 2023.
- Fortress Biotech, Inc. net cash provided by (used in) financing activities for fiscal 2023 was $32.74M, a 56.53% decline from fiscal 2022.
- Fortress Biotech, Inc. net cash provided by (used in) financing activities for fiscal 2022 was $75.32M, a 49.45% decline from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 6 month as first filed | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 9 month as first filed | Net Cash Provided by (Used in) Financing Activities 12 month | Net Cash Provided by (Used in) Financing Activities 12 month as first filed | Net Cash Provided by (Used in) Financing Activities 63 month | Net Cash Provided by (Used in) Financing Activities 66 month | Net Cash Provided by (Used in) Financing Activities 69 month | Net Cash Provided by (Used in) Financing Activities 72 month | Net Cash Provided by (Used in) Financing Activities 75 month | Net Cash Provided by (Used in) Financing Activities 78 month | Net Cash Provided by (Used in) Financing Activities 81 month | Net Cash Provided by (Used in) Financing Activities 84 month | Net Cash Provided by (Used in) Financing Activities 87 month | Net Cash Provided by (Used in) Financing Activities 90 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $91.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$27.30M 10-Q · filed 2026-08-13 | -$21.59M derived: sum of 3 quarters · filed 2026-08-13 | -$6.52M derived: sum of 4 quarters · filed 2026-08-13 | |||||||||||||
| 2026-03-31 | -$27.39M 10-Q · filed 2026-05-14 | -$21.68M derived: sum of 2 quarters · filed 2026-05-14 | -$6.61M derived: sum of 3 quarters · filed 2026-05-14 | -$2.09M derived: sum of 4 quarters · filed 2026-08-13 | |||||||||||||
| 2025-12-31 | $5.71M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $20.78M derived: sum of 2 quarters · filed 2026-03-31 | $25.30M derived: sum of 3 quarters · filed 2026-08-13 | $77.44M 10-K · filed 2026-03-31 | |||||||||||||
| 2025-09-30 | $15.07M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $19.59M derived: sum of 2 quarters · filed 2026-08-13 | $71.73M 10-Q · filed 2025-11-14 | $97.54M derived: sum of 4 quarters · filed 2026-08-13 | |||||||||||||
| 2025-06-30 | $4.52M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $56.66M 10-Q · filed 2026-08-13 | $82.47M derived: sum of 3 quarters · filed 2026-08-13 | $85.18M derived: sum of 4 quarters · filed 2026-08-13 | |||||||||||||
| 2025-03-31 | $52.14M 10-Q · filed 2026-05-14 | $77.95M derived: sum of 2 quarters · filed 2026-05-14 | $80.66M derived: sum of 3 quarters · filed 2026-05-14 | $94.92M derived: sum of 4 quarters · filed 2026-05-14 | |||||||||||||
| 2024-12-31 | $25.81M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $28.52M derived: sum of 2 quarters · filed 2026-03-31 | $42.78M derived: sum of 3 quarters · filed 2026-03-31 | $70.64M 10-K · filed 2026-03-31 | |||||||||||||
| 2024-09-30 | $2.71M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $16.98M derived: sum of 2 quarters · filed 2025-11-14 | $44.84M 10-Q · filed 2025-11-14 | $88.45M derived: sum of 4 quarters · filed 2025-11-14 | |||||||||||||
| 2024-06-30 | $14.27M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $42.12M 10-Q · filed 2025-08-14 | $85.74M derived: sum of 3 quarters · filed 2025-08-14 | $83.06M derived: sum of 4 quarters · filed 2025-08-14 | |||||||||||||
| 2024-03-31 | $27.86M 10-Q · filed 2025-05-15 | $71.48M derived: sum of 2 quarters · filed 2025-05-15 | $68.79M derived: sum of 3 quarters · filed 2025-05-15 | $38.41M derived: sum of 4 quarters · filed 2025-05-15 | |||||||||||||
| 2023-12-31 | $43.62M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $40.93M derived: sum of 2 quarters · filed 2025-03-31 | $10.55M derived: sum of 3 quarters · filed 2025-03-31 | $32.74M 10-K · filed 2025-03-31 | |||||||||||||
| 2023-09-30 | -$2.69M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | -$33.07M derived: sum of 2 quarters · filed 2024-11-14 | -$10.88M 10-Q · filed 2024-11-14 | $7.74M derived: sum of 4 quarters · filed 2024-11-14 | |||||||||||||
| 2023-06-30 | -$30.38M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | -$8.19M 10-Q · filed 2024-08-13 | $10.42M derived: sum of 3 quarters · filed 2024-08-13 | $14.17M derived: sum of 4 quarters · filed 2024-08-13 | |||||||||||||
| 2023-03-31 | $22.19M 10-Q · filed 2024-05-15 | $40.80M derived: sum of 2 quarters · filed 2024-05-15 | $44.55M derived: sum of 3 quarters · filed 2024-05-15 | $47.54M derived: sum of 4 quarters · filed 2024-05-15 | |||||||||||||
| 2022-12-31 | $18.62M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $22.36M derived: sum of 2 quarters · filed 2024-03-28 | $25.36M derived: sum of 3 quarters · filed 2024-03-28 | $75.32M 10-K · filed 2024-03-28 | |||||||||||||
| 2022-09-30 | $3.75M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $6.74M derived: sum of 2 quarters · filed 2023-11-14 | $56.70M 10-Q · filed 2023-11-14 | $95.64M derived: sum of 4 quarters · filed 2023-11-14 | |||||||||||||
| 2022-06-30 | $2.99M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $52.95M 10-Q · filed 2023-08-14 | $91.90M derived: sum of 3 quarters · filed 2023-08-14 | $98.86M derived: sum of 4 quarters · filed 2023-08-14 | |||||||||||||
| 2022-03-31 | $49.96M 10-Q · filed 2023-05-15 | $88.91M derived: sum of 2 quarters · filed 2023-05-15 | $95.87M derived: sum of 3 quarters · filed 2023-05-15 | $120.27M derived: sum of 4 quarters · filed 2023-05-15 | |||||||||||||
| 2021-12-31 | $38.94M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $45.91M derived: sum of 2 quarters · filed 2023-03-31 | $70.30M derived: sum of 3 quarters · filed 2023-03-31 | $148.99M 10-K · filed 2023-03-31 | |||||||||||||
| 2021-09-30 | $6.97M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $31.36M derived: sum of 2 quarters · filed 2022-11-14 | $110.05M 10-Q · filed 2022-11-14 | $147.07M derived: sum of 4 quarters · filed 2022-11-14 | |||||||||||||
| 2021-06-30 | $24.39M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $103.09M 10-Q · filed 2022-08-11 | $140.10M derived: sum of 3 quarters · filed 2022-08-11 | $186.93M derived: sum of 4 quarters · filed 2022-08-11 | |||||||||||||
| 2021-03-31 | $78.69M 10-Q · filed 2022-05-12 | $115.71M derived: sum of 2 quarters · filed 2022-05-12 | $162.54M derived: sum of 3 quarters · filed 2022-05-12 | $228.35M derived: sum of 4 quarters · filed 2022-05-12 | |||||||||||||
| 2020-12-31 | $37.02M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-28 | $83.85M derived: sum of 2 quarters · filed 2022-03-28 | $149.66M derived: sum of 3 quarters · filed 2022-03-28 | $172.41M 10-K · filed 2022-03-28 | |||||||||||||
| 2020-09-30 | $46.83M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $112.64M derived: sum of 2 quarters · filed 2021-11-15 | $135.40M 10-Q · filed 2021-11-15 | $162.55M derived: sum of 4 quarters · filed 2021-11-15 | |||||||||||||
| 2020-06-30 | $65.81M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | $88.56M 10-Q · filed 2021-08-16 | $115.72M derived: sum of 3 quarters · filed 2021-08-16 | $121.27M derived: sum of 4 quarters · filed 2021-08-16 | |||||||||||||
| 2020-03-31 | $22.75M 10-Q · filed 2021-05-17 | $49.91M derived: sum of 2 quarters · filed 2021-05-17 | $55.46M derived: sum of 3 quarters · filed 2021-05-17 | $117.35M derived: sum of 4 quarters · filed 2021-05-17 | |||||||||||||
| 2019-12-31 | $27.16M derived: 10-K/A 12 month − 10-Q 9 month · filed 2021-04-09 | $32.71M derived: sum of 2 quarters · filed 2021-04-09 | $94.60M derived: sum of 3 quarters · filed 2021-04-09 | $146.71M 10-K/A · filed 2021-04-09 | |||||||||||||
| 2019-09-30 | $5.55M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $67.45M derived: sum of 2 quarters · filed 2020-11-09 | $119.56M 10-Q · filed 2020-11-09 | $117.87M derived: sum of 4 quarters · filed 2020-11-09 | |||||||||||||
| 2019-06-30 | $61.89M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $114.01M 10-Q · filed 2020-08-10 | $112.31M derived: sum of 3 quarters · filed 2020-08-10 | $122.27M derived: sum of 4 quarters · filed 2020-08-10 | |||||||||||||
| 2019-03-31 | $52.11M 10-Q · filed 2020-05-11 | $50.42M derived: sum of 2 quarters · filed 2020-05-11 | $60.38M derived: sum of 3 quarters · filed 2020-05-11 | $63.11M derived: sum of 4 quarters · filed 2020-05-11 | |||||||||||||
| 2018-12-31 | -$1.69M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | $8.26M derived: sum of 2 quarters · filed 2020-03-16 | $10.99M derived: sum of 3 quarters · filed 2020-03-16 | $50.65M 10-K · filed 2020-03-16 | |||||||||||||
| 2018-09-30 | $9.96M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $12.69M derived: sum of 2 quarters · filed 2019-11-12 | $52.34M 10-Q · filed 2019-11-12 | $54.00M 10-Q · filed 2018-11-09 | $73.00M derived: sum of 4 quarters · filed 2019-11-12 | ||||||||||||
| 2018-06-30 | $2.73M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $42.38M 10-Q · filed 2019-08-09 | $44.04M 10-Q · filed 2018-08-09 | $63.04M derived: sum of 3 quarters · filed 2019-08-09 | $80.18M derived: sum of 4 quarters · filed 2019-08-09 | ||||||||||||
| 2018-03-31 | $39.66M 10-Q · filed 2019-05-10 | $60.31M derived: sum of 2 quarters · filed 2019-05-10 | $77.45M derived: sum of 3 quarters · filed 2019-05-10 | $131.88M derived: sum of 4 quarters · filed 2019-05-10 | |||||||||||||
| 2017-12-31 | $20.66M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18 | $37.80M derived: sum of 2 quarters · filed 2019-03-18 | $92.22M derived: sum of 3 quarters · filed 2019-03-18 | $150.38M 10-K · filed 2019-03-18 | $154.21M 10-K · filed 2018-03-16 | ||||||||||||
| 2017-09-30 | $17.14M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | $71.56M derived: sum of 2 quarters · filed 2018-11-09 | $129.72M 10-Q · filed 2018-11-09 | $155.68M derived: sum of 4 quarters · filed 2018-11-09 | |||||||||||||
| 2017-06-30 | $54.42M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $112.58M 10-Q · filed 2018-08-09 | $138.54M derived: sum of 3 quarters · filed 2018-08-09 | ||||||||||||||
| 2017-03-31 | $58.16M 10-Q · filed 2018-05-10 | $84.11M derived: sum of 2 quarters · filed 2018-05-10 | |||||||||||||||
| 2016-12-31 | $25.95M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | $42.91M 10-K · filed 2018-03-16 | |||||||||||||||
| 2016-09-30 | $16.95M 10-Q · filed 2017-11-09 | ||||||||||||||||
| 2015-12-31 | $60.92M 10-K · filed 2018-03-16 | ||||||||||||||||
| 2013-12-31 | $387.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-14 | $45.91M derived: sum of 2 quarters · filed 2014-03-14 | $77.81M derived: sum of 3 quarters · filed 2014-03-14 | $89.16M 10-K · filed 2014-03-14 | $180.61M 10-K · filed 2014-03-14 | ||||||||||||
| 2013-09-30 | $45.52M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-01 | $77.42M derived: sum of 2 quarters · filed 2013-11-01 | $88.77M 10-Q · filed 2013-11-01 | $88.87M derived: sum of 4 quarters · filed 2014-03-14 | $180.22M 10-Q · filed 2013-11-01 | ||||||||||||
| 2013-06-30 | $31.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-05 | $43.25M 10-Q · filed 2013-08-05 | $43.35M derived: sum of 3 quarters · filed 2014-03-14 | $57.28M derived: sum of 4 quarters · filed 2014-03-14 | $134.70M 10-Q · filed 2013-08-05 | ||||||||||||
| 2013-03-31 | $11.35M 10-Q · filed 2013-05-09 | $11.45M derived: sum of 2 quarters · filed 2014-03-14 | $25.38M derived: sum of 3 quarters · filed 2014-03-14 | $102.80M 10-Q · filed 2013-05-09 | |||||||||||||
| 2012-12-31 | $105.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-14 | $14.03M derived: sum of 2 quarters · filed 2014-03-14 | $40.51M 10-K · filed 2014-03-14 | $91.45M 10-K · filed 2013-03-18 | |||||||||||||
| 2012-09-30 | $13.93M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-01 | $40.41M 10-Q · filed 2013-11-01 | $91.35M 10-Q · filed 2012-11-14 | ||||||||||||||
| 2012-06-30 | $26.48M 10-Q · filed 2013-08-05 | $77.42M 10-Q · filed 2012-08-08 | |||||||||||||||
| 2012-03-31 | $0.00 derived: 10-Q 69 month − 10-K 66 month · filed 2012-05-15 | $113.00K derived: sum of 2 quarters · filed 2014-03-14 | $107.00K derived: sum of 3 quarters · filed 2014-03-14 | $50.94M 10-Q · filed 2012-05-15 | |||||||||||||
| 2011-12-31 | $113.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-14 | $107.00K derived: sum of 2 quarters · filed 2014-03-14 | $23.09M 10-K · filed 2014-03-14 | $50.94M 10-K · filed 2012-03-29 | |||||||||||||
| 2011-09-30 | -$6.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-14 | $22.98M 10-Q · filed 2012-11-14 | $50.83M 10-Q · filed 2011-11-14 | ||||||||||||||
| 2011-06-30 | $22.99M 10-Q · filed 2012-08-08 | ||||||||||||||||
| 2010-12-31 | -$55.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | $19.04M 10-K · filed 2013-03-18 | |||||||||||||||
| 2010-09-30 | $19.10M 10-Q · filed 2011-11-14 | ||||||||||||||||
| 2009-12-31 | $3.86M 10-K · filed 2012-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 |